Skip to content

Clinical trials

Cardiomyopathies trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Italy Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20051
20101
20131
20142
20152
20161
20171
20185
20193
20204
20214
20221
202311
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting16
Unknown status9
Terminated2
Enrolling by invitation1
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna5
Alnylam Pharmaceuticals4
Abbott Medical Devices2
Ancora Heart, Inc.2
Bambino Gesù Hospital and Research Institute2
Bayer2
Eidos Therapeutics, a BridgeBio company2
Federico II University2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Ionis Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies49
Heart Failure19
Amyloidosis10
Amyloid Neuropathies, Familial7
Cardiomyopathy, Dilated6
Heart Diseases5
Arrhythmias, Cardiac4
Alzheimer Disease3
Cardiomyopathy, Hypertrophic3
Myocarditis3

Trials

Showing 76 to 49 of 49. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.